BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 25661348)

  • 21. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
    Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
    Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
    Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
    Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
    Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
    Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells.
    Jo H; Park Y; Kim T; Kim J; Lee JS; Kim SY; Chung JI; Ko HY; Pyun JC; Kim KS; Lee M; Yun M
    BMC Cancer; 2020 Apr; 20(1):332. PubMed ID: 32306906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCU-dependent mitochondrial Ca
    Ren T; Zhang H; Wang J; Zhu J; Jin M; Wu Y; Guo X; Ji L; Huang Q; Zhang H; Yang H; Xing J
    Oncogene; 2017 Oct; 36(42):5897-5909. PubMed ID: 28650465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest.
    Wilson JM; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    J Surg Res; 2014 Oct; 191(2):280-5. PubMed ID: 24996256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirt3 promotes hepatocellular carcinoma cells sensitivity to regorafenib through the acceleration of mitochondrial dysfunction.
    Wang R; Liu Y; Mi X; Chen Q; Jiang P; Hou J; Lin Y; Li S; Ji B; Fang Y
    Arch Biochem Biophys; 2020 Aug; 689():108415. PubMed ID: 32562663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.
    Baek SY; Hwang UW; Suk HY; Kim YW
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32375410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma.
    Dai X; Wang L; Deivasigamni A; Looi CY; Karthikeyan C; Trivedi P; Chinnathambi A; Alharbi SA; Arfuso F; Dharmarajan A; Goh BC; Hui KM; Kumar AP; Mustafa MR; Sethi G
    Oncotarget; 2017 Feb; 8(8):12831-12842. PubMed ID: 28086233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 6-Shogaol induces cell cycle arrest and apoptosis in human hepatoma cells through pleiotropic mechanisms.
    Wu JJ; Omar HA; Lee YR; Teng YN; Chen PS; Chen YC; Huang HS; Lee KH; Hung JH
    Eur J Pharmacol; 2015 Sep; 762():449-58. PubMed ID: 26101062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin.
    Pi H; Xu S; Reiter RJ; Guo P; Zhang L; Li Y; Li M; Cao Z; Tian L; Xie J; Zhang R; He M; Lu Y; Liu C; Duan W; Yu Z; Zhou Z
    Autophagy; 2015; 11(7):1037-51. PubMed ID: 26120888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    Lim SC; Choi JE; Kang HS; Han SI
    Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
    Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
    Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
    Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
    Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In Vivo.
    Zhang X; Wang Y; Han S; Xiang H; Peng Y; Wu Y; Pan S; Zhang Y; Ruan J
    PLoS One; 2016; 11(3):e0151679. PubMed ID: 26974964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma.
    Lee JH; Lee H; Yun SM; Jung KH; Jeong Y; Yan HH; Hong S; Hong SS
    Cancer Lett; 2013 Feb; 329(1):99-108. PubMed ID: 23142281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of SIRT3 in regulating proliferation of hepatocellular carcinoma cells in vitro].
    Tao Y; Chen J
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):195-9. PubMed ID: 26922015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
    Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
    Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SIRT3 suppression resulting from the enhanced β-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells.
    Ma R; Gao QY; Chen ZT; Liao GH; Li ST; Cai JW; Luo NS; Chen H; Zhang HF
    Cell Cycle; 2024 Feb; 23(4):435-447. PubMed ID: 38626328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.